What is the Immunotherapy cost in India?

Here you will find complete information about the cost of immunotherapy by types as well as consultation cost for hospitals that provide immunotherapy in India

By Vishal Bondre

Updated on 11th, Mar'20

The immunotherapy cost in India ranges from ₹1,50,000 ($2,091) - ₹4,55,000 ($6500) per session.

 

However, the costs can differ depending on various factors that play a major role in deciding the immunotherapy cost in India.

 

Immunotherapy cost in India is comparatively low and way more economical.

 

The treatment provided here is high-class in quality and much lesser than any other developed country which provides Immunotherapy. Immunotherapy in India has been on a successful path since a long time and it keeps on improving day by day.

 

Immunotherapy, like any complex cancer treatment, requires specialized cancer department. We have listed down all the best cancer hospital that provide holistic cancer treatment in India, where you can go to by clicking here.

 

We Will first look at all the costs that come before the actual immunotherapy or pre-treatment costs.

 

Additional costs:

There are certain other expenses that are accompanied along with immunotherapy cost in India. Before starting immunotherapy, the doctor will prescribe few tests in order to know whether the person is healthy enough to receive immunotherapy.

 

These add on to the cost of immunotherapy for cancer treatment.

 

For your reference we have listed down all the costs you will incur in this treatment.

TestsDescription
Consultation feesThe consultation fess may vary from ₹1000 ($14) to ₹5000 ($71) depending on the fees of the medical oncologist.
Investigation testsBefore giving immunotherapy, there are certain tests performed like blood tests, urine tests, ECG (Electrocardiogram), CBC (complete blood count), etc. in order to know the health of the patient and whether he or she is fit for immunotherapy or not. Their cost may range from ₹56,000 ($800) to ₹70,000 ($1000).
PDL1 testThis test measures the amount of the PDL1 on cancer cells. The cost of PDL1 varies from ₹15000 ($214) to ₹30,000 ($428).
Extra medications costAfter receiving immunotherapy, you may suffer from some side – effects. To minimize the side – effects, you may be given extra medications. This will add up to your cost of immunotherapy.

Here we have listed costs of Immunotherapy treatments in India by different prominent types of cancers:

 

1. Immunotherapy for bladder cancer

Immunotherapy is given for the advanced bladder cancer as a first line treatment who are ineligible for cisplatin chemotherapy.

 

Immunotherapy improves the outcome of the bladder cancer and reduces the risk of recurrence of bladder cancer. Also, it improves the survival rate of the patient.

 

BCG is the first approved immunotherapy and stimulates the immune response which targets the bacteria as well as bladder cancer cells nearby.

 

The drugs used in immunotherapy for bladder cancer are:

  1. Atezolizumab (Tecentriq)
  2. Durvalumab (Imfinzi)
  3. Nivolumab (Opdivo®)
  4. Pembrolizumab (keytruda)

The 5 – year survival rate for patient with bladder cancer in advanced stageis 34% and in case of metastases, its 5%.

The cost of drugs of immunotherapy in India for bladder cancer is:

MedicineAmount
Atezolizumab (Tecentriq)Rs.1,98,000($2,759)
durvalumab (Imfinzi)Rs.1,38,000 ($ 3,328.18)
Nivolumab (Opdivo)₹99,291 ($1,383)
Pembrolizumab (keytruda)₹1,50,000 to 1,60,000($2091 to $2,230)


 

2. Immunotherapy for breast cancer

Breast cancer is one of the most common type of cancer among women.

 

Atezolizumab (Tecentriq) is the first immunotherapy drug that is approved in India for treating triple negative breast cancer.

 

Other immunotherapy drugs are currently under testing in breast cancer clinical trials and some of them have shown extremely good results.

 

The cost of drugs of immunotherapy in India for breast cancer are:

MedicineAmount
Atezolizumab (Tecentriq)Rs 1,98,000($2,759)

 

3. Immunotherapy for cervical cancer

Cervical cancer is the fourth most common cancer seen in women in the world. Most of the cases of the cervical cancer are associated with HPV (human papilloma virus) infection.

Preventive vaccines are given in order to prevent the infection by HPV that can cause cervical cancer.

The 5 – year survival rate for patient with cervical cancer in advanced stage is 17%.

The cost of drugs of immunotherapy in India for cervical cancer are:

MedicineAmount
Pembrolizumab (keytruda)₹1,50,000 to 1,60,000($2091 to $2,230)

 

4. Immunotherapy for colorectal cancer

Colorectal cancer refers to both colon cancer and rectal cancer.

 

Immunotherapy can be given in two types. Either a monoclonal antibody targets the EGFR pathway or it can target the VEGF/ VEGFR2 pathway and prevent the tumor blood vessel growth.

 

The 5 – year survival rate for patient with colorectal cancer in advanced stage is 15%.

 

The cost of drugs of immunotherapy in India for colorectal cancer are:

MedicineAmount
Pembrolizumab (keytruda)₹1,50,000 to 1,60,000($2091 to $2,230)
Nivolumab (Opdivo)₹99,291 ($1,383)

 

5. Immunotherapy for Oesophageal cancer

The two main types of oesophageal cancer are squamous cell carcinoma and adenocarcinoma. The immunotherapy for oesophageal cancer work in three ways:

  • A monoclonal antibody targets the VEGF/VEGFR2 pathway and restricts tumor blood vessel growth.
  • A monoclonal antibody targets the HER2 pathway.
  • A immune checkpoint inhibitor targets the PD – 1/PD – L1 pathway.

The 5 – year survival rate for patient with Oesophagealcancer in advanced stage is 5%.

The cost of drugs of immunotherapy in India for oesophageal cancer are:

Targeted Antibodies
MedicineAmount
Ramucirumab (Cyramza)1,60,000to 2,00,000 ($2,230 to 2788)
Trastuzumab (Herceptin--
Immunomodulators
Pembrolizumab (keytruda)₹1,50,000 to 1,60,000($2091 to $2,230)

 

6. Immunotherapy for head and neck cancer

Head and neck cancer includedifferent types of cancer that includes the mouth, throat, voice box, nose cavity and salivary glands.

 

The immunotherapy for head and neck cancer can be given in two ways:

  • A monoclonal antibody targets the EGFR pathway
  • A checkpoint inhibitor targeting the P – 1/ PD – L1 pathway

The cost of drugs of immunotherapy in India for head and neck cancer are:

Targeted Antibodies
MedicineAmount
Cetuximab (Erbitux)₹1,01,000 ($1,408)
Immunomodulators
Nivolumab (Opdivo):₹99,291 ($1,383)
Pembrolizumab (keytruda)₹1,50,000 to 1,60,000($2091 to $2,230)

 

7. Immunotherapy for kidney cancer

Almost 9 out of 10 people suffering from kidney cancer have renal cell carcinomas which is the cancer formed in the lining of the tubules inside the kidney.

 

Immunotherapy is given in the form of immune – stimulating chemicals called cytokines for advanced cancer.

 

The 5 – year survival rate for patient with kidney cancer in advanced stage is 5%.

 

The cost of drugs of immunotherapy in India for kidney cancer are:

MedicineAmount
Avelumab (Bavencio)₹86,860($1,223)
ipilimumab (Yervoy)--
Interleukin-2 (IL-2)₹42,958($605)
Interferon-alfa--


 

Factors affecting immunotherapy cost in India:

The immunotherapy cost for cancer can be different for different patients. The following factors play a major role in deciding the cost of immunotherapy:

  • Metastasis of cancer: A crucial factor in deciding the immunotherapy cost in India is how far the cancer has spread and what all parts are affected by the cancer. If the cancer has not affected more organs of the body, then the cost of immunotherapy will be relatively lower.
  • Type of cancer: Immunotherapy is not the treatment option for all type of cance₹ The cost of immunotherapy is different for different types of cancer. Depending on the type of cancer a patient has, immunotherapy type and drugs will be decided thus affecting the cost of immunotherapy in India.
  • Health of the patient: Basically, immunotherapy is a treatment where your immune cells are treated in way so that they are made capable of fighting cancer. So, your actual health also plays a major role in deciding the cost of immunotherapy.
  • Duration of the treatment: The duration of the treatment is another important factor in deciding the cost of immunotherapy in India. It is dependent on the number of sessions you require. The duration is decided based on following factors mainly type and grade of cancer.
  • Treatment plan: At times, you are not given immunotherapy alone. You may have undergone chemotherapy, radiation or surgery at the beginning followed by immunotherapy thereby increasingthe total cost of the treatment.
  • Types of the drugs used: In immunotherapy, there are different types of drugs whose cost are also different. The doctor will decide the drugs which will be used for the treatment and accordingly it will affect the cost of immunotherapy.

 

Immunotherapy in India as compared to other developed countries:

CountriesCost (In Rupees)
India₹1,00,000- ₹4,30,000
United States₹1,22,44,500.00- ₹1,36,05,000
Canada₹53,31,830.00- ₹58,60,523.05
Germany₹8,24,951.46- ₹10,58,254.03

Immunotherapy cost in India is very low as compared to the other countries like US, UK and Singapore.

 

The above graph shows that there is a huge difference in the cost of immunotherapy in India and other countries.

 

Let us tell you why there is such a wide difference in the cost between the countries:

  • Indian currency: The major reason of this huge difference in immunotherapy cost in India is the currency. The Indian currency is quite low as compared to dollar, euro, etc. Thus, the cost of the treatment is less as compared to other countries.
  • Living cost: The living cost in India is almost 65% lower as compared to the other developed countries. Therefore, you can get all the facilities at a very low cost.
  • Competition: Well, India is a place where you have abundant choices of hospitals. All these hospitals offer a variety of medical treatment. So, therefore you can choose as per your convenience from a wide range of hospitals.

 

Success Rate of Immunotherapy in India

The success rate of immunotherapy in India has seen a tremendous increase. The five - year survival rate of immunotherapy has increased from 5.5% in 2012 to 28 % in 2019. While other cancer treatments like chemotherapy, radiation, etc. cannot give this high survival rate at the stage IV cancer, immunotherapy becomes one of the leading choice to get better results.


Assistance, Over Call

Provide your details, and our expert will get in touch with you.

Name

Please enter Country code

Mobile

Email

Please enter a valid email